RNS Number : 4131G
  GW Pharmaceuticals PLC
  22 October 2008
   

    GW Pharmaceuticals plc

    Notification of Results


    Porton Down, UK, 22 October 2008: GW Pharmaceuticals plc (AIM: GWP) will be announcing its preliminary financial results for the year to
30 September 2008 on Tuesday 18 November 2008.  

    Enquiries:

 Financial Dynamics  020 7831 3113
 Ben Atwell


    Notes to Editors

    About GW
    GW was founded in 1998 and listed on the AiM, a market of the London Stock Exchange, in June 2001. Operating under license from the UK
Home Office, the company researches and develops cannabinoid pharmaceutical products for patients who suffer from a range of serious
ailments, in particular pain and other neurological symptoms. GW has assembled a team of over 100 scientists with extensive experience in
developing both plant-based prescription pharmaceutical products and medicines containing controlled substances. GW occupies a world leading
position in cannabinoids and has developed an extensive international network of the most prominent scientists in the field. 


    For further information, please visit the Company's website: www.gwpharm.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
NORVLLBLVBBXFBV
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Gw Pharmaceuticals Charts.
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Gw Pharmaceuticals Charts.